Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Larsen

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 21, 2001
Recruitment of cdc2 kinase by DNA topoisomerase II is coupled to chromatin remodelingA E Escargueil, S Y Plisov, A Skladanowski, et al.
Biochemistry|May 7, 1996
Modulation of DNA topoisomerase I activity by p53C Gobert, L Bracco, F Rossi, et al.
Molecular Pharmacology|May 1, 1995
Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosisH M Beere, C M Chresta, A Alejo-Herberg, et al.
Cancer Research|April 18, 2001
Unusual potency of BN 80915, a novel fluorinated E-ring modified camptothecin, toward human colon carcinoma cellsA K Larsen, C Gilbert, G Chyzak, et al.
Oncogene|January 7, 1998
Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 functionZ Cai, C Capoulade, C Moyret-Lalle, et al.
Biochemical Pharmacology|August 3, 1994
Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivativesJ Markovits, A K Larsen, E Ségal-Bendirdjian, et al.
Blood|June 20, 1998
Endomitosis of human megakaryocytes are due to abortive mitosisN Vitrat, K Cohen-Solal, C Pique, et al.
Cancer Research|December 15, 1993
Intoplicine (RP 60475) and its derivatives, a new class of antitumor agents inhibiting both topoisomerase I and II activitiesJ F Riou, P Fossé, C H Nguyen, et al.
Cancer Research|September 15, 1989
Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase IIJ Markovits, C Linassier, P Fossé, et al.
Clinical Nutrition ESPEN|March 25, 2019
Protein and energy intake improved by in-between meals: An intervention study in hospitalized patientsM N Mortensen, A K Larsen, L B Skadhauge, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 21, 2001
Recruitment of cdc2 kinase by DNA topoisomerase II is coupled to chromatin remodelingA E Escargueil, S Y Plisov, A Skladanowski, et al.
Biochemistry|May 7, 1996
Modulation of DNA topoisomerase I activity by p53C Gobert, L Bracco, F Rossi, et al.
Molecular Pharmacology|May 1, 1995
Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosisH M Beere, C M Chresta, A Alejo-Herberg, et al.
Cancer Research|April 18, 2001
Unusual potency of BN 80915, a novel fluorinated E-ring modified camptothecin, toward human colon carcinoma cellsA K Larsen, C Gilbert, G Chyzak, et al.
Oncogene|January 7, 1998
Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 functionZ Cai, C Capoulade, C Moyret-Lalle, et al.
Biochemical Pharmacology|August 3, 1994
Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivativesJ Markovits, A K Larsen, E Ségal-Bendirdjian, et al.
Blood|June 20, 1998
Endomitosis of human megakaryocytes are due to abortive mitosisN Vitrat, K Cohen-Solal, C Pique, et al.
Cancer Research|December 15, 1993
Intoplicine (RP 60475) and its derivatives, a new class of antitumor agents inhibiting both topoisomerase I and II activitiesJ F Riou, P Fossé, C H Nguyen, et al.
Cancer Research|September 15, 1989
Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase IIJ Markovits, C Linassier, P Fossé, et al.
Clinical Nutrition ESPEN|March 25, 2019
Protein and energy intake improved by in-between meals: An intervention study in hospitalized patientsM N Mortensen, A K Larsen, L B Skadhauge, et al.
Pageof 7